Communiqués Cell Impact AB

Actions

CI

SE0025940513

Machines et équipements industriels

Temps Différé Nasdaq Stockholm 16:55:28 01/10/2026			Varia. 5j.	Varia. 1 janv.
0,0301 ^SEK	+1,35%		+1,69%	-81,30%

29/09	20 actions ont atteint aujourd’hui un nouveau plus bas sur 52 semaines à la Bourse de Stockholm	FW
22/09	16 actions ont jusqu’ici inscrit aujourd’hui un nouveau plus bas sur 52 semaines à la Bourse de Stockholm	FW

Communiqués

23/09	Cell Impact appoints Mangold Fondkommission as new Certified Adviser	AQ
01/09	Cell Impact carries out a directed share issue to the underwriter in connection with the completed rights issue	AQ
21/08	Cell Impact announces outcome of the company's rights issue	AQ
19/08	The last day for subscription in Cell Impact AB's ongoing rights issue of units is tomorrow, 20 August 2026	AQ
17/08	Last day of trading in unit rights in Cell Impact's rights issue	AQ
14/08	Cell Impact's CEO, Daniel Vallin, has conducted a CEO interview with Mangold Insight	AQ
13/08	Members of the company's Board of Directors and management subscribe for units in Cell Impact's ongoing rights issue of units	AQ
06/08	The subscription period in Cell Impact's rights issue of units starts today	AQ
05/08	Cell Impact Q2 2026: Progress continues despite prolonged lead times	AQ
31/07	Communiqué from the Extraordinary General Meeting of Cell Impact AB (publ)	AQ
02/07	CFO Malin Lundberg to leave Cell Impact	AQ
29/06	NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF CELL IMPACT AB (PUBL)	AQ
29/06	Cell Impact resolves on a rights issue of units of approximately SEK 53.6 million and procures a bridge loan of SEK 15 million	AQ
27/06	Cell Impact receives order worth SEK 5.3 million	AQ
17/06	Cell Impact reports limited liquidity following delayed transaction	AQ
13/05	Cell Impact : 2026 Q1 Interim Report	PU
13/05	Cell Impact Q1 2026: Measured progress in a turbulent hydrogen market	AQ
23/04	Communiqué from the Annual General Meeting 2026 of Cell Impact AB (publ)	AQ
06/03	Last day of trading in Cell Impact BTA - conversion of BTA into shares	AQ
04/03	Cell Impact carries out a directed share issue to guarantors and a directed issue of warrants to lender	AQ
25/02	Cell Impact in replacement agreement, receives 6 MSEK	AQ
24/02	Cell Impact announces outcome of rights issue	AQ
05/02	Cell Impact publishes information document regarding the rights issue	AQ
04/02	Cell Impact : 2025 Q4 Year-end Report	PU
04/02	Cell Impact Q4 2025: Growth and expansion of the business paving the way forward	AQ